Melanoma Research Foundation
The Melanoma Research Foundation (MRF) is the largest independent organization devoted to melanoma. The MRF is a 501(c)(3) nonprofit organization. Committed to the support of […]
The Melanoma Research Foundation (MRF) is the largest independent organization devoted to melanoma. The MRF is a 501(c)(3) nonprofit organization. Committed to the support of […]
A Phase II Study of Pemetrexed (Alimta) as Second-Line Therapy for Hormone Refractory Prostate Cancer: Hoosier Oncology Group GU03-67
LUNGevity is changing outcomes for people with lung cancer through research, education, and support. We are dedicated to funding scientific research because the link between […]
Following is a cumulative list of Hoosier Cancer Research Network publications in prostate cancer.
For the third consecutive year, Hoosier Cancer Research Network chairman Christopher A. Fausel, PharmD, is combining his passion for investigator-initiated research with his annual participation […]
Hoosier Cancer Research Network chairman Christopher A. Fausel, PharmD, is once again combining his passion for investigator-initiated research with his annual participation in the Arnold […]
In a new journal article published online ahead of print in Supportive Care in Cancer, Hoosier Cancer Research Network investigators reported on results of QL12-153, […]
We are pleased to announce that LUN-116 abstract has been published in the November 2010 issue of the Journal of Thoracic Oncology. Congratulations to Dr. Hanna and […]
This website is owned and operated by Hoosier Cancer Research Network, Inc. (HCRN). Because we gather certain types of information about our users, you should […]
A Phase II Randomized Controlled Trial of Genomically Directed Therapy After Preoperative Chemotherapy in Patients with Triple Negative Breast Cancer.
Thanks for pledging your support for Chris Fausel’s “Reps for Research” challenge! We will contact you following the event with results and a link to […]
Moffitt Cancer Center is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only […]
The Indiana Department of the Ladies Auxiliary to the Veterans of Foreign Wars recently donated nearly $12,500 to Hoosier Cancer Research Network (formerly known as […]
Following is a cumulative list of Hoosier Cancer Research Network publications in kidney cancer.
Former Hoosier Cancer Research Network vice-chair Robin T. Zon, MD, FACP, FASCO, will chair an Education Session during the American Society of Clinical Oncology (ASCO) […]
Pemetrexed (Alimta) in Patients with Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer
A Phase I/II Study of Carboplatin/Nab-Paclitaxel and MK-3475 for Advanced Non-Small Cell Lung Cancer (NSCLC): HCRN LUN13-175
A Phase II Trial of VP-16, Ifosfamide and Cisplatin (VIP) Combination Chemotherapy for Previously Untreated Extensive Small Cell Lung Cancer
Hoosier Cancer Research Network (HCRN), a nonprofit cancer research organization in Indianapolis, recently welcomed Chris Wayne, vice president of oncology at Community Health Network, as […]
The Prostate Cancer Foundation (PCF) is the world’s leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised more than […]
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter